<DOC>
	<DOCNO>NCT00003122</DOCNO>
	<brief_summary>RATIONALE : Surgery may effective treatment neuroblastoma . PURPOSE : This phase II trial study well surgery work treat patient neuroblastoma .</brief_summary>
	<brief_title>Surgery Treating Patients With Neuroblastoma</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate safety efficacy surgical treatment alone stage II neuroblastoma without N-myc amplification ( NMA ) . - Describe predictive factor relapse survival stage I II neuroblastoma without NMA treat surgery alone . OUTLINE : Patients localize resectable tumor undergo surgery . Postoperative evaluation perform 30 day follow surgery . Study patient stage I ( without N-myc amplification ) tumor trial patient stage II tumor receive therapy . Study patient ( except stage I patient ) receive surgery and/or chemotherapy accord protocol necessary disease progression relapse . Patients follow every 3 month first year , every 4 6 month second third year respectively , yearly 5 year . PROJECTED ACCRUAL : This study accrue 140 stage II patient trial portion rate 40 per year 3.5 year . At least 70 patient accrue study portion .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Trial : Histologically prove International Neuroblastoma Staging System ( INSS ) stage IIA IIB neuroblastoma without amplification Nmyc oncogene Study : Histologically prove neuroblastoma Stage I Stage II amplify Nmyc Stage II without evaluation Nmyc Stage II symptomatic spinal cord compression Stage III No metastasis diagnose within 1 month study PATIENT CHARACTERISTICS : Age : 20 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy No adjuvant chemotherapy plan Endocrine therapy : Prior use steroid allow Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>localize resectable neuroblastoma</keyword>
	<keyword>localize unresectable neuroblastoma</keyword>
</DOC>